Intravenous immunoglobulin for the treatment of Kawasaki disease in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for the Treatment of Kawasaki Disease in Children." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433374/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children.
Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433374/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children. Accessed December 7, 2024.
Intravenous immunoglobulin for the treatment of Kawasaki disease in children. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433374/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease in Children [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433374/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for the treatment of Kawasaki disease in children
ID - 433374
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433374/all/Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease_in_children
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -